Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 183 entries
View as:

To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination

Phase: N/A Priority: Normal
NCT ID: NCT05737771 Org: User:
Start: 01/25/23 End: 06/30/23 Due: 06/30/24

The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients

Phase: N/A Priority: Normal
NCT ID: NCT01397240 Org: User:
Start: 07/31/11 End: 06/30/13 Due: 06/30/14

Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine

Phase: N/A Priority: Normal
NCT ID: NCT01094847 Org: User:
Start: 04/30/10 End: - Due: -

Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03016494 Org: User:
Start: 02/29/16 End: - Due: -

Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)

Phase: N/A Priority: Normal
NCT ID: NCT04064073 Org: User:
Start: 08/14/19 End: 11/20/19 Due: 11/20/20

To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy

Phase: N/A Priority: Normal
NCT ID: NCT05410535 Org: User:
Start: 09/15/21 End: 10/28/22 Due: 10/28/23

Study of DWJ1351 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02665832 Org: User:
Start: 01/31/16 End: 06/30/16 Due: 06/30/17

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02952755 Org: User:
Start: 11/28/16 End: 12/20/16 Due: 12/20/17

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT06141980 Org: User:
Start: 12/31/23 End: 09/30/25 Due: 09/30/26

Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm

Phase: N/A Priority: Normal
NCT ID: NCT02947815 Org: User:
Start: 10/31/16 End: 01/31/18 Due: 01/31/19

Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02704559 Org: User:
Start: 12/31/15 End: 02/29/16 Due: 02/28/17

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.

Phase: N/A Priority: Normal
NCT ID: NCT05376930 Org: User:
Start: 09/16/21 End: 05/31/22 Due: 05/31/23

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)

Phase: N/A Priority: Normal
NCT ID: NCT06121830 Org: User:
Start: 08/31/23 End: 03/31/25 Due: 03/31/26

Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05812404 Org: User:
Start: 10/26/22 End: 06/16/23 Due: 06/16/24

A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2

Phase: N/A Priority: Normal
NCT ID: NCT04721535 Org: User:
Start: 06/07/21 End: 10/06/21 Due: 10/06/22

Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate

Phase: N/A Priority: Normal
NCT ID: NCT05083299 Org: User:
Start: 01/28/20 End: 01/20/22 Due: 01/20/23

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)

Phase: N/A Priority: Normal
NCT ID: NCT04167267 Org: User:
Start: 11/30/19 End: 01/31/20 Due: 01/31/21

A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab

Phase: N/A Priority: Normal
NCT ID: NCT05660122 Org: User:
Start: 11/11/22 End: 07/31/25 Due: 07/31/26

Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT06272630 Org: User:
Start: 02/06/23 End: 03/29/24 Due: 03/29/25

A Single Dose Study of DWP10292 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01423526 Org: User:
Start: 08/31/11 End: 02/29/12 Due: 02/28/13

To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT06866509 Org: User:
Start: 02/28/22 End: 02/28/24 Due: 02/28/25

Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy

Phase: N/A Priority: Normal
NCT ID: NCT02909270 Org: User:
Start: 08/31/16 End: - Due: -

Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04278391 Org: User:
Start: 07/02/19 End: 02/19/20 Due: 02/19/21

An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05832697 Org: User:
Start: 01/27/22 End: 01/30/23 Due: 01/30/24

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT03024086 Org: User:
Start: 12/12/16 End: 04/25/17 Due: 04/25/18